Longevity Health Holdings annual stock-based compensation
2021
2022
2023
2024
2025
Longevity Health Holdings Stock-Based Compensation Growth & History (XAGE)
Longevity Health Holdings's stock-based compensation was $692,790 for fiscal 2025.
View full Longevity Health Holdings company overviewLongevity Health Holdings annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $692,790 | −$134,253 | −16.23% |
| 2024 | 2024-12-31 | $827,043 | $159,361 | +23.87% |
| 2023 | 2023-12-31 | $667,682 | $31,314 | +4.92% |
| 2022 | 2022-12-31 | $636,368 | $636,368 | — |
| 2021 | 2021-12-31 | $0 | — | — |
Longevity Health Holdings quarterly stock-based compensation
Q3.21
Q1.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $78,759 | −$115,564 | −59.47% |
| Q1 2026 | 2026-03-31 | $145,927 | $31,098 | +27.08% |
| Q4 2025 | 2025-12-31 | $193,712 | −$72,466 | −27.22% |
| Q3 2025 | 2025-09-30 | $189,926 | $4,230 | +2.28% |
| Q2 2025 | 2025-06-30 | $194,323 | $30,623 | +18.71% |
| Q1 2025 | 2025-03-31 | $114,829 | −$96,640 | −45.70% |
| Q4 2024 | 2024-12-31 | $266,178 | $203,795 | +326.68% |
| Q3 2024 | 2024-09-30 | $185,696 | −$52,064 | −21.90% |
| Q2 2024 | 2024-06-30 | $163,700 | −$23,330 | −12.47% |
| Q1 2024 | 2024-03-31 | $211,469 | $30,960 | +17.15% |
| Q4 2023 | 2023-12-31 | $62,383 | — | — |
| Q3 2023 | 2023-09-30 | $237,760 | −$39,874 | −14.36% |
| Q2 2023 | 2023-06-30 | $187,030 | — | — |
| Q1 2023 | 2023-03-31 | $180,509 | $180,509 | — |
| Q3 2022 | 2022-09-30 | $277,634 | $277,634 | — |
| Q1 2022 | 2022-03-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
Longevity Health Holdings stock-based compensation trends
Between the periods ended 2021-12-31 and 2025-12-31, Longevity Health Holdings's stock-based compensation increased from $0 to $692,790, a change of $692,790. The latest reported quarter, Q2 2026, shows $78,759.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Longevity Health Holdings source filings ↗